May 30, 2007

Florida University Research Funds Up $36.5 Million in 2006

Filed under: Other Regional News — admin @ 3:41 pm

MIAMI, FL—Public and private sector investments in research at major Florida universities were up $36.5 million between 2005 and 2006, totaling more than $1.6 billion in 2006, according to a new survey. (more…)

May 25, 2007

Out of region VCs see promise in the southeast

Filed under: SEBIO in the News — admin @ 1:25 pm

by Stephanie Adams
Executive Director, Southeast BIO

Large and impressive displays by Southeastern states at last week’s BIO International Convention in Boston are evidence of the importance of the biotech industry to the economic growth of the individual states and the region as a whole. (more…)

May 24, 2007

Biolex Therapeutics Raises $30 Million

Filed under: Regional Venture News — admin @ 3:43 pm

Pittsboro, NC: Biolex Therapeutics, a privately held biopharmaceutical company, announced today the closing of a $30 million Series C financing. (more…)

May 9, 2007

IDEA Fund Partners announces initial closing of its inaugural IDEA Fund I

Filed under: Regional Venture News — admin @ 3:45 pm

Research Triangle Park, NC– IDEA Fund Partners, a new venture capital partnership targeting investment in seed and early stage companies, has announced initial closing of its inaugural IDEA Fund I. (more…)

May 2, 2007

Cumberland Pharmaceuticals Files for $115 Million IPO

Filed under: Regional Venture News — admin @ 3:47 pm

Nashville, TN: Cumberland Pharmaceuticalshas filed its registration with the Securities and Exchange Commission for its initial public offering. The Nashville company wants to raise $115 million by offering a yet undetermined amount of shares.

http://nashville.bizjournals.com/nashville/stories/2007/04/30/daily21.html

Pasteuria Bioscience Raises $5.3M in Series B

Filed under: Regional Venture News — admin @ 12:38 pm

Alachua, FL– Pasteuria Bioscience, a Florida based agricultural biotech company, announced today that it has completed the $ 5.3 million closing of a series B financing round led by LSP BioVentures who joined existing Series A investors, Advantage Capital and Gordon River Capital. (more…)